Diet-induced hyperhomocysteinemia increases amyloid-beta formation and deposition in a mouse model of Alzheimer's disease.

Current Alzheimer Research
J-M ZhuoDomenico Praticò

Abstract

Hyperhomocysteinemia (HHcy) has been recognized as a risk factor for developing Alzheimer's disease (AD). However, its underlying molecular mechanisms are still elusive. Here we show that HHcy induces an elevation of amyloid beta (Abeta) levels and deposition, as well as behavioral impairments, in a mouse model of AD-like amyloidosis, the Tg2576 mice. This elevation is not associated with significant change of the steady state levels of the Abeta precursor protein (APP), beta- or alpha-secretase pathways, nor with the Abeta catabolic pathways. By contrast, HHcy significantly reduces glycogen synthase kinase 3 (GSK3) Ser21/9 phosphorylation, but not total GSK3 protein levels. Similar results are obtained in brains homogenates from a genetic mouse model of HHcy. In vitro studies show that homocysteine increases Abeta formation, reduces phosphorylated GSK3 levels, without changes in total APP and its metabolism, and these effects are prevented by selective GSK3 inhibition. Overall, these data support a potential link between GSK3 and the pro-amyloidotic effect of HHcy in vivo and in vitro.

Citations

Jun 4, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jia-Min Zhuo, Domenico Praticò
Jan 25, 2013·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Lei FengMichael W L Chee
Jun 21, 2011·Trends in Pharmacological Sciences·Jia-Min ZhuoDomenico Praticò
Aug 27, 2010·Rapid Communications in Mass Spectrometry : RCM·Jacqueline L Mann, W Robert Kelly
Nov 9, 2010·Journal of Neurochemistry·Alexander McCampbellMary Savage
Jan 7, 2015·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Seong Hyeok ParkKang Joon Lee
Mar 22, 2014·Frontiers in Molecular Neuroscience·Jean-Marie Sontag, Estelle Sontag
May 13, 2014·Bioorganic & Medicinal Chemistry Letters·Antonella ConversoRena Zhang
Jul 21, 2012·PloS One·Dapeng LiangHongxing Lei
Jun 19, 2016·Biochimica Et Biophysica Acta·Rajib Paul, Anupom Borah
Apr 20, 2016·Journal of Thrombosis and Haemostasis : JTH·Y C ChungE H Norris
Nov 30, 2016·Aging Cell·Jian-Guo LiDomenico Praticò
Apr 7, 2017·Scientific Reports·Jian-Guo LiDomenico Praticò
Jan 21, 2016·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·M FangX Liu
Dec 20, 2017·Journal of Alzheimer's Disease : JAD·Antonio Di MecoDomenico Praticò
May 6, 2019·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Yuan ShenChun-Feng Liu
Feb 13, 2020·Brain Structure & Function·Miriam Palomar-BonetJose L Cantero
Aug 4, 2020·American Journal of Physiology. Endocrinology and Metabolism·Nicole ZeltserMagdalena Maj
Dec 11, 2019·Drug Development Research·Pooja PatilSwaran Jeet Singh Flora
Nov 4, 2020·The Proceedings of the Nutrition Society·Marina Souza MatosMirela Delibegović
Dec 31, 2020·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Yuze CaoJun Ni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.